BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16603206)

  • 21. Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments.
    Sakakima Y; Hayakawa A; Nagasaka T; Nakao A
    J Hepatol; 2007 Jul; 47(1):83-92. PubMed ID: 17399847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
    Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesis.
    Kang JS; Wanibuchi H; Murai T; Morimura K; Kinoshita A; Fukushima S
    Oncol Rep; 2007 Apr; 17(4):747-52. PubMed ID: 17342310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells.
    Geisler I; Kopp-Schneider A
    Math Biosci; 2000 Dec; 168(2):167-85. PubMed ID: 11121564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mathematical modelling of liver regeneration after intoxication with CCl(4).
    Höhme S; Hengstler JG; Brulport M; Schäfer M; Bauer A; Gebhardt R; Drasdo D
    Chem Biol Interact; 2007 May; 168(1):74-93. PubMed ID: 17442287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of the role of hepatic oval cell in primary hepatocarcinogenesis using specific Y chromosome].
    Fang CH; Chen TJ; Liu SJ
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1501-4. PubMed ID: 17349181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of Ginkgo biloba against rat liver carcinogenesis.
    Dias MC; Rodrigues MA; Reimberg MC; Barbisan LF
    Chem Biol Interact; 2008 May; 173(1):32-42. PubMed ID: 18367157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
    Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evolutive characters of oval cells in experimental hepatocarcinogenesis].
    Chen QR; Xiang J; Liao B; Liu QB; Che LH; Xue L; Zhao GQ
    Ai Zheng; 2007 Jul; 26(7):719-23. PubMed ID: 17626747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promotion potential of madder color in a medium-term multi-organ carcinogenesis bioassay model in F344 rats.
    Yokohira M; Yamakawa K; Hosokawa K; Matsuda Y; Kuno T; Saoo K; Imaida K
    J Food Sci; 2008 Apr; 73(3):T26-32. PubMed ID: 18387132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stochastic analysis of intermediate lesions in carcinogenesis experiments.
    Luebeck EG; Moolgavkar SH
    Risk Anal; 1991 Mar; 11(1):149-57. PubMed ID: 1828119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats.
    Chakraborty T; Swamy AH; Chatterjee A; Rana B; Shyamsundar A; Chatterjee M
    J Cell Biochem; 2007 May; 101(1):244-58. PubMed ID: 17243116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats.
    Ramakrishnan G; Raghavendran HR; Vinodhkumar R; Devaki T
    Chem Biol Interact; 2006 Jun; 161(2):104-14. PubMed ID: 16643877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoplastic progression in experimental hepatocarcinogenesis.
    Scherer E
    Biochim Biophys Acta; 1984; 738(4):219-36. PubMed ID: 6394049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in DNA damage and repair produced by systemic, hepatocarcinogenic and sarcomagenic dibenzocarbazole derivatives in a model of rat liver progenitor cells.
    Valovicová Z; Marvanová S; Mészárosová M; Srancíková A; Trilecová L; Milcová A; Líbalová H; Vondrácek J; Machala M; Topinka J; Gábelová A
    Mutat Res; 2009 Jun; 665(1-2):51-60. PubMed ID: 19427511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered gene expression of transcriptional regulatory factors in tumor marker-positive cells during chemically induced hepatocarcinogenesis.
    Osada S; Naganawa A; Misonou M; Tsuchiya S; Tamba S; Okuno Y; Nishikawa J; Satoh K; Imagawa M; Tsujimoto G; Sugimoto Y; Nishihara T
    Toxicol Lett; 2006 Dec; 167(2):106-13. PubMed ID: 16997513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of hepatocarcinogenesis in humans and animal models.
    Köhle C; Schwarz M; Bock KW
    Arch Toxicol; 2008 Sep; 82(9):623-31. PubMed ID: 18204979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year.
    Tasaki M; Umemura T; Inoue T; Okamura T; Kuroiwa Y; Ishii Y; Maeda M; Hirose M; Nishikawa A
    Toxicology; 2008 Sep; 250(2-3):143-50. PubMed ID: 18675878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Textural modifications in hepatocytes as a result of the action of N-nitrosomorpholine].
    Pellín A; Gil Benso R; Cabanes J; Llombart Bosch A
    Rev Esp Oncol; 1983; 30(4):501-5. PubMed ID: 6599914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.